- 346
- 77 948
LSX Leaders
United Kingdom
เข้าร่วมเมื่อ 13 ก.ค. 2015
Welcome to LSX TV on TH-cam.
LSX (formerly Biotech and Money) is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Visit www.biotechandmoney.com.
LSX TV is the official community library of digital video interviews. The interviews are short and sharp, offering insights into the minds of c-suite executives on highly topical issues.
LSX (formerly Biotech and Money) is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Visit www.biotechandmoney.com.
LSX TV is the official community library of digital video interviews. The interviews are short and sharp, offering insights into the minds of c-suite executives on highly topical issues.
AI-Powered Insights Revolutionizing Pharma BD Deals
AI-Powered Insights: Revolutionizing Pharma BD Deals
Tuesday 11th June 2024
2:00 PM BST
A panel discussion with:
Roby Kanichay, Head of Technologies and Externalizations Business Development, Merck
David Linson, Senior Director-Business Operations and Intelligence, Eli Lilly
Alexandria Hall, Head of Industry, LifeSciences, Alphasense
Ivan Griffin, Co-Founder, BenevolentAl
Steve Lehmann, Director, Venture Operations, Portal Innovations
In the dynamic landscape of pharmaceutical business development (BD), the integration of artificial intelligence (AI) has emerged as a transformative force, reshaping traditional approaches to deal-making. AI-powered insights offer unparalleled capabilities in data analysis, predictive modeling, and decision support, empowering pharmaceutical companies to navigate complex deal structures with precision and agility. This panel discussion delves into the profound impact of AI on pharma BD deals, exploring how advanced analytics and machine learning algorithms are revolutionizing the negotiation process, driving strategic partnerships, and unlocking new avenues for growth and innovation.
Harnessing data intelligence for strategic decision-making
Optimizing deal valuation and risk assessment with predictive analytics
Enhancing due diligence and partner selection processes
Driving innovation and strategic partnerships through AI collaboration
Tuesday 11th June 2024
2:00 PM BST
A panel discussion with:
Roby Kanichay, Head of Technologies and Externalizations Business Development, Merck
David Linson, Senior Director-Business Operations and Intelligence, Eli Lilly
Alexandria Hall, Head of Industry, LifeSciences, Alphasense
Ivan Griffin, Co-Founder, BenevolentAl
Steve Lehmann, Director, Venture Operations, Portal Innovations
In the dynamic landscape of pharmaceutical business development (BD), the integration of artificial intelligence (AI) has emerged as a transformative force, reshaping traditional approaches to deal-making. AI-powered insights offer unparalleled capabilities in data analysis, predictive modeling, and decision support, empowering pharmaceutical companies to navigate complex deal structures with precision and agility. This panel discussion delves into the profound impact of AI on pharma BD deals, exploring how advanced analytics and machine learning algorithms are revolutionizing the negotiation process, driving strategic partnerships, and unlocking new avenues for growth and innovation.
Harnessing data intelligence for strategic decision-making
Optimizing deal valuation and risk assessment with predictive analytics
Enhancing due diligence and partner selection processes
Driving innovation and strategic partnerships through AI collaboration
มุมมอง: 225
วีดีโอ
Capital Markets & Deal Making 2024 Expectations
มุมมอง 4148 หลายเดือนก่อน
Capital Markets & Deal-Making 2024 Expectations: A Beaming Horizon of Opportunity, Innovation, Investments, and Partnerships Tuesday 20th February 2024 2:00 PM GMT A panel discussion with: Jane Buus Laursen, Corporate VP, Business Development, Novo Nordisk Michael Rice, Founding Partner, LifeSci Advisors Tim Haines, Managing Director, Abingworth Marta Helena Lesko, VP Business Development, Merc...
Reverse Mergers: Planning and Executing a Path to Public Capital
มุมมอง 32010 หลายเดือนก่อน
Reverse Mergers: Planning and Executing a Path to Public Capital A panel discussion with: - Michael Cunniffe, Managing Director, Danforth Advisors - Alan Selby, Managing Director, Stifel Financial Corp. - David Stewart, Partner & Chair of London Capital Markets, Latham & Watkins - Luke Marshall, Sales Director, DFIN Discover the intricacies of reverse mergers and gain valuable insights into tak...
LSX World Congress 2023
มุมมอง 25010 หลายเดือนก่อน
LSX World Congress 2023 The LSX channel features sessions from LSX events, where our mission is to connect senior #biotech, #medtech & #healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. Subscribe to our channel for more videos. Follow us on Twitter: LSXLeaders Visit us at www.lsxleaders.com
Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L
มุมมอง 13811 หลายเดือนก่อน
A panel discussion with: • Ed Kivell, Life Sciences lead EMEA/APAC, AlphaSense • Matthias Mullenbeck, SVP, Head Global Business Development & Alliance Management, Merck • Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics • Martin-Immanuel Bittner, Co-Founder and CEO, Arctoris • Marko Kuisma, Partner, Innovestor In the rapidly evolving landscape of biopharmac...
Planning for Cell & Gene Therapy Commercialization
มุมมอง 568ปีที่แล้ว
Planning for Cell & Gene Therapy Commercialization A panel discussion with: Matt Booth, SVP Global Therapy Lead, ApotheCom, An Inizio Company Ben Beckley, President, Evoke Mind Matter, An Inizio Company Dean McAlister, EVP, Inizio Biotech Greg Christianson, Principal, Nuvera, An Inizio Company Rita Johnson-Greene, COO, Alliance for Regenerative Medicine (ARM) Bringing cell & gene therapies ...
RNA Leaders
มุมมอง 61ปีที่แล้ว
Discover how industry leaders are innovating to overcome delivery bottlenecks, explore the latest in RNA biomarkers, and learn about RNA-based approaches to target cancer and advance emerging areas such as RNA editing, non-linear RNAs, and small molecule strategies. Join us in September 2023 in Boston Visit us at www.lsxleaders.com/rna-leaders-usa-congress
LSX World Congress
มุมมอง 74ปีที่แล้ว
The LSX channel features sessions from LSX events, where our mission is to connect senior #biotech, #medtech & #healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. Subscribe to our channel for more videos. Follow us on Twitter: LSXLeaders Visit us at www.lsxleaders.com
Biopharma M&A + Investment During a Downturn
มุมมอง 171ปีที่แล้ว
Applying Modern Market Intelligence and Innovative Strategies A panel discussion with: * Matthias Muellenbeck, SVP, Head of Global Business Development & Alliance Management, Merck KGaA * Stephanie Sirota, Partner & Chief Business Officer, RTW Investments * Ed Kivell, VP of Global Strategic Accounts EMEA/APAC, AlphaSense * Michael Margolis, Senior Managing Director, Co-Head of Healthcare Invest...
LSX World Congress USA, Boston Sept 2023 - Biotechnology, Medical Devices, Digital Health Investment
มุมมอง 272ปีที่แล้ว
For nearly a decade, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making. LSX World Congress USA gathers the founders and CEOs of innovative start-ups through to publicly listed healthcare giants, and everyone in between. It represents the breadth and depth of cutting-edge rese...
LSX World Congress 2023
มุมมอง 8Kปีที่แล้ว
LSX was born with the simple mission to connect life science executives with the partners they need to flourish. Events now take place in London, Boston and Copenhagen. The 9th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core. The event brings together the CEOs and senior decision makers from the world's most innova...
Interview with Dominik Witzigmann
มุมมอง 201ปีที่แล้ว
We are at a historical moment in humankind Interview with Dominik Witzigmann Co-founding CEO of NanoVation Therapeutics In March 2022, we spoke to Dominik and asked him about what excites him about the field of RNA and why he decided to join RNA Leaders. Subscribe to our channel for more videos. Follow us on LinkedIn: www.linkedin.com/showcase/rnaleaders/ Visit us at www.lsxleaders.com/rna-lead...
Interview with Melissa Moore at RNA Leaders Europe 2022
มุมมอง 663ปีที่แล้ว
In March 2022, we grabbed Mellisa and asked her about emerging technologies that excite her within the RNA, what to expect from Moderna in the next few years and how she finds being back in person after the pandemic. RNA Leaders is a high-quality therapeutic conference, focussed on presentation of pre-clinical and clinical data from companies who are developing new RNA medicines. Join us on 15-...
Understanding Patient Access Programs
มุมมอง 6722 ปีที่แล้ว
Understanding Patient Access Programs & Their Strategic Utility During Pre- or Post-Market Clinical Trials Early reimbursement planning can be critical to a company’s successful launch of an emerging or innovative healthcare technology. This includes what occurs during the pivotal trial evaluating a particular product. Technologies involved in upcoming or ongoing research should understand the ...
Navigating the Global IVD Landscape
มุมมอง 7882 ปีที่แล้ว
Hear from Industry Experts in the U.S., Europe, and Japan on key regulatory and clinical trends around the world • James Mullally, Ph.D., Vice President, IVD Regulatory Affairs, US, MCRA Former FDA Assistant Director, Chemistry and Toxicology Devices Division • Erica Conway, Ph.D., Vice President, IVD Regulatory Affairs, Europe, MCRA Former Head of Notified Body - IVD at BSI • Samuel Pollard, G...
How to navigate your late-stage biotech fundraising in the current economic climate
มุมมอง 2312 ปีที่แล้ว
How to navigate your late-stage biotech fundraising in the current economic climate
Future Operating Room - Understanding digital trends & uncovering impacts
มุมมอง 2302 ปีที่แล้ว
Future Operating Room - Understanding digital trends & uncovering impacts
Masterclass: M&A - A Refresh For The Current Market
มุมมอง 1152 ปีที่แล้ว
Masterclass: M&A - A Refresh For The Current Market
Masterclass: Preparing For Your IPO - Strategies For Success
มุมมอง 2662 ปีที่แล้ว
Masterclass: Preparing For Your IPO - Strategies For Success
Masterclass: Planning & Implementing Successful Digital Health Projects
มุมมอง 1562 ปีที่แล้ว
Masterclass: Planning & Implementing Successful Digital Health Projects
Masterclass: Protecting Your IP And Innovation
มุมมอง 1122 ปีที่แล้ว
Masterclass: Protecting Your IP And Innovation
Food Biotech: US investor insights session
มุมมอง 662 ปีที่แล้ว
Food Biotech: US investor insights session
Scaling fermentation and cultivation enabled product to speed of traditional CPG
มุมมอง 1432 ปีที่แล้ว
Scaling fermentation and cultivation enabled product to speed of traditional CPG
Plant-Based Food Science & Design: You can’t have one without the other
มุมมอง 1982 ปีที่แล้ว
Plant-Based Food Science & Design: You can’t have one without the other
Food Biotech: European investor insights session
มุมมอง 112 ปีที่แล้ว
Food Biotech: European investor insights session
Successful partnering with FMCG/CPG, Ingredient companies, plant-based foods or retailers
มุมมอง 572 ปีที่แล้ว
Successful partnering with FMCG/CPG, Ingredient companies, plant-based foods or retailers
Delivering clean flavours, colourants, preservatives, and antioxidants
มุมมอง 362 ปีที่แล้ว
Delivering clean flavours, colourants, preservatives, and antioxidants
Technology Insights Hub - Clean label sugar reduction advancements
มุมมอง 312 ปีที่แล้ว
Technology Insights Hub - Clean label sugar reduction advancements
So this is the asshole who wants to charge sick kids $35,000/yr for ordinary CBD??! Talk about the banality of evil.
Many people are not happy with your fraud, watch your back
What exactly are you referring to?
Thor GW Pharma is the only company in the U.K. granted a licence to make their product from cannabis. The government doesn't want to legalise for medical use, or even decriminalise, and even though government has granted this licence For a Pharma company to grow cannabis for medical use, the government in defence on the non legalisation say "cannabis has no medical value " Also or then Prime minister Theresa May, well her husband had a hedge fund, and guess what, invested heavily, And our own drugs minister yes her husband was a top man for British sugar now helping to grow for GW Pharma, but then there was money for posh expensive hotels given by British Sugar for a political conference, it's a huge piss take and political fraud, the usual cronyism.
@@jaypicard6198 I see. Thanks for the explanation.